Cargando…

The BCL2-938 C > A promoter polymorphism is associated with risk group classification in children with acute lymphoblastic leukemia

BACKGROUND: Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer. While current treatment regimens achieve almost 80% overall survival, long-term side effects of chemotherapeutic agents can be severe. The functional BCL2-938C > A promoter polymorphism is known to influence the b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Künkele, Annette, Grosse-Lordemann, Anja, Schramm, Alexander, Eggert, Angelika, Schulte, Johannes H, Bachmann, Hagen S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850706/ https://www.ncbi.nlm.nih.gov/pubmed/24088574 http://dx.doi.org/10.1186/1471-2407-13-452

Ejemplares similares

The BCL2 -938C>A Promoter Polymorphism Is Associated with Risk for and Time to Aseptic Loosening of Total Hip Arthroplasty
por: Stelmach, Patrick, et al.
Publicado: (2016)

BCL-2 (-938C > A) polymorphism is associated with breast cancer susceptibility
por: Zhang, Ning, et al.
Publicado: (2011)

BCL2-938C > A and CALCA-1786T > C polymorphisms in aseptic loosened total hip arthroplasty
por: Wedemeyer, C, et al.
Publicado: (2009)

Role of Bcl-2 -938 C>A polymorphism in susceptibility and prognosis of cancer: a meta-analysis
por: Zhang, Xiao, et al.
Publicado: (2014)

Sinusoidal Obstruction Syndrome Following Myeloablative Therapy and Tranexamic Acid Treatment for Hemorrhage in Two Patients with Neuroblastoma
por: Zirngibl, Felix, et al.
Publicado: (2020)

RITA displays anti-tumor activity in medulloblastomas independent of TP53 status
por: Gottlieb, Aline, et al.
Publicado: (2017)

BCL-2 (-938C>A), BAX (-248G>A), and HER2 Ile655Val Polymorphisms and Breast Cancer Risk in Indian Population
por: Bhatt, Deepti, et al.
Publicado: (2021)

Damping of the 938 MHz RF cavity resonance
por: Lauckner, R J, et al.
Publicado: (1983)

BCL6 modulation of acute lymphoblastic leukemia response to chemotherapy
por: Slone, William L., et al.
Publicado: (2016)

The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastoma
por: Pajtler, Kristian W, et al.
Publicado: (2013)

The -938C>A Polymorphism in MYD88 Is Associated with Susceptibility to Tuberculosis: A Pilot Study
por: Aggelou, Kalliopi, et al.
Publicado: (2016)

MIR938 rs2505901 T>C polymorphism is associated with increased neuroblastoma risk in Chinese children
por: Jiang, Susu, et al.
Publicado: (2023)

Rationale for targeting BCL6 in MLL-rearranged acute lymphoblastic leukemia
por: Hurtz, Christian, et al.
Publicado: (2019)

Case report: HLA-haploidentical HSCT rescued with donor lymphocytes infusions in a patient with X-linked chronic granulomatous disease
por: Scheiermann, Julia, et al.
Publicado: (2023)

RBP2 Promotes Adult Acute Lymphoblastic Leukemia by Upregulating BCL2
por: Wang, Xiaoming, et al.
Publicado: (2016)

938 Pregnancy and COVID-19: the impact on maternal mental health
por: Quistorff, Jessica L., et al.
Publicado: (2021)

Association of miR-938G>A Polymorphisms with Primary Ovarian Insufficiency (POI)-Related Gene Expression
por: Cho, Sung Hwan, et al.
Publicado: (2017)

Fast, In Vivo Model for Drug-Response Prediction in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia
por: Gauert, Anton, et al.
Publicado: (2020)

Reactivating TP53 signaling by the novel MDM2 inhibitor DS-3032b as a therapeutic option for high-risk neuroblastoma
por: Arnhold, Viktor, et al.
Publicado: (2017)

The small molecule Bcl-2/Mcl-1 inhibitor TW-37 shows single-agent cytotoxicity in neuroblastoma cell lines
por: Klenke, Stefanie, et al.
Publicado: (2019)

Therapeutic Targeting of MERTK and BCL-2 in T-Cell and Early T-Precursor Acute Lymphoblastic Leukemia
por: Summers, Ryan J., et al.
Publicado: (2022)

Inhibiting Lysine Demethylase 1A Improves L1CAM-Specific CAR T Cell Therapy by Unleashing Antigen-Independent Killing via the FAS-FASL Axis
por: Sulejmani, Ornela, et al.
Publicado: (2021)

Thiopurine methyltransferase polymorphisms in children with acute lymphoblastic leukemia
por: Linga, Vijay Gandhi, et al.
Publicado: (2014)

BCL6 inhibition ameliorates resistance to ruxolitinib in CRLF2-rearranged acute lymphoblastic leukemia
por: Tsuzuki, Shinobu, et al.
Publicado: (2022)

The Effect of B-Cell Lymphoma 2 and BCL2-Associated X Polymorphisms on the Survival of Acute Lymphoblastic Leukemia Patients: Application of Frailty Survival Models
por: Nikmohammadi, Navideh, et al.
Publicado: (2022)

Ikaros regulation of the BCL6/BACH2 axis and its clinical relevance in acute lymphoblastic leukemia
por: Ge, Zheng, et al.
Publicado: (2016)

The acute lymphoblastic leukemia prognostic scoring whether it is possible by BCL-2, BAX gene promoter genotyping
por: Moazami-Goudarzi, Mozhagan, et al.
Publicado: (2016)

The Role of Interleukin-15 Polymorphisms in Adult Acute Lymphoblastic Leukemia
por: Lin, Dandan, et al.
Publicado: (2010)

ITPA Polymorphisms and the Incidence of Toxicities in Children with Acute Lymphoblastic Leukemia
por: Svasdisant, Patpetra, et al.
Publicado: (2023)

The 938 MHz resonant damping loops for the 200 MHz SPS travelling wave cavities
por: Caspers, F, et al.
Publicado: (2012)

A unified catalog of 204,938 reference genomes from the human gut microbiome
por: Almeida, Alexandre, et al.
Publicado: (2020)

Tumor-Derived Extracellular Vesicles Impair CD171-Specific CD4(+) CAR T Cell Efficacy
por: Ali, Solin, et al.
Publicado: (2020)

Association of TLX1 gene polymorphisms with the risk of acute lymphoblastic leukemia and B lineage acute lymphoblastic leukemia in Han Chinese children
por: Mei, Endian, et al.
Publicado: (2020)

Analysis of the expression pattern of the BCL11B gene and its relatives in patients with T-cell acute lymphoblastic leukemia
por: Huang, Xin, et al.
Publicado: (2010)

Enhanced levels of the apoptotic BAX/BCL-2 ratio in children with acute lymphoblastic leukemia and high-risk features
por: Kaparou, Maria, et al.
Publicado: (2013)

BCL6 enables Ph(+) acute lymphoblastic leukemia cells to survive BCR-ABL1 kinase inhibition
por: Duy, Cihangir, et al.
Publicado: (2011)

BIM mediates synergistic killing of B-cell acute lymphoblastic leukemia cells by BCL-2 and MEK inhibitors
por: Korfi, K, et al.
Publicado: (2016)

Targeting Apoptosis Pathways With BCL2 and MDM2 Inhibitors in Adult B-cell Acute Lymphoblastic Leukemia
por: Hohtari, Helena, et al.
Publicado: (2022)

The oncogenetic landscape and clinical impact of BCL11B alterations in adult and pediatric T-cell acute lymphoblastic leukemia
por: Dourthe, Marie Emilie, et al.
Publicado: (2023)

bcl‐2 Regulation in Normal Resting Lymphocytes and Lymphoblasts
por: Kendo, Eisaku, et al.
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_n0b7t6drg00dl6mnbcfb2h2rj2